Patents Assigned to Plexus Worldwide, LLC.
  • Publication number: 20250134945
    Abstract: Various embodiments provide a method of increasing immunity to a virus in a subject. The method can comprise administering to the subject one or more effective doses of an immune-enhancing natural-based composition; thereby stimulating increased expression one or more of IFN-?, IL-1B, IL-6, IL-10, IL-12p40, IL-12p70, and TNF-?; inhibiting replication of the virus inside a cell of the subject, and preventing entry of virus into the cell. The method of increasing immunity can further comprise increasing immunity to an upper respiratory tract viral infection. The upper respiratory tract viral infection can be COVID-19. According to some aspects of the method of increasing immunity, the effective dose of the immune-enhancing natural-based composition comprises: 30-70 mgs of cyanidin-3-glucosides; 40-80 mgs of andrographolides; 75-125 mgs of ascorbic acid; 400-600 mgs of beta glucans; 300-500 mgs of polysaccharides; and 75-125 mgs of a blend of antioxidants.
    Type: Application
    Filed: January 6, 2025
    Publication date: May 1, 2025
    Applicant: Plexus Worldwide, LLC
    Inventors: Michael Hartman, Lauren Knutsen, Michael Rogowski
  • Patent number: 12186358
    Abstract: Various embodiments provide a method of increasing immunity to a virus in a subject. The method can comprise: administering to the subject one or more effective doses of an immune-enhancing natural-based composition; thereby stimulating increased expression one or more of IFN-?, IL-1B, IL-6, IL-10, IL-12p40, IL-12p70, and TNF-?; inhibiting replication of the virus inside a cell of the subject, and preventing entry of virus into the cell. The method of increasing immunity can further comprise increasing immunity to an upper respiratory tract viral infection. The upper respiratory tract viral infection can be COVID-19. According to some aspects of the method of increasing immunity, the effective dose of the immune-enhancing natural-based composition comprises: 30-70 mgs of cyanidin-3-glucosides; 40-80 mgs of andrographolides; 75-125 mgs of ascorbic acid; 400-600 mgs of beta glucans; 300-500 mgs of polysaccharides; and 75-125 mgs of a blend of antioxidants.
    Type: Grant
    Filed: February 17, 2022
    Date of Patent: January 7, 2025
    Assignee: Plexus Worldwide, LLC
    Inventors: Michael Hartman, Lauren Knutsen, Michael Rogowski
  • Publication number: 20230302029
    Abstract: Various embodiments of a gut microbiome modulating composition comprises a blend of a polyphenol and an oligosaccharide. Various embodiments of the polyphenol may comprise at least approximately 5% by weight chlorogenic acid. Various embodiments of the oligosaccharides may be standardized to a degree of polymerization of at least three to reduce digestibility. Administration of an effective amount of the gut microbiome modulating composition to a person or animal may stimulate the growth of at least one of Akkermansia muciniphila, Lactobacillus, and Bifidobacterium bacteria in the colon, which may reduce permeability of the colon, increases short chain fatty acid production in the colon, and/or modulate causes immunomodulation of human colon cells. The gut microbiome modulating composition may provide protective effects against obesity-related chronic diseases.
    Type: Application
    Filed: May 26, 2023
    Publication date: September 28, 2023
    Applicant: Plexus Worldwide, LLC.
    Inventors: Stephen Roman, Tianan Jiang, Marco Rebaza
  • Patent number: 11730749
    Abstract: Various embodiments of a gut microbiome modulating composition comprises a blend of a polyphenol and an oligosaccharide. Various embodiments of the polyphenol may comprise at least approximately 5% by weight chlorogenic acid. Various embodiments of the oligosaccharides may be standardized to a degree of polymerization of at least three to reduce digestibility. Administration of an effective amount of the gut microbiome modulating composition to a person or animal may stimulate the growth of at least one of Akkermansia muciniphila, Lactobacillus, and Bifidobacterium bacteria in the colon, which may reduce permeability of the colon, increases short chain fatty acid production in the colon, and/or modulate causes immunomodulation of human colon cells. The gut microbiome modulating composition may provide protective effects against obesity-related chronic diseases.
    Type: Grant
    Filed: May 7, 2018
    Date of Patent: August 22, 2023
    Assignee: Plexus Worldwide, LLC
    Inventors: Stephen Roman, Tianan Jiang, Marco Rebaza
  • Publication number: 20230060688
    Abstract: Various embodiments provide topical compositions and methods for treating the skin to modulate the skin microbiome. The application of various embodiments of the topical composition may modulate the growth of various commensal bacterial in the skin microbiome when applied to the skin, which may improve the immune function of the skin and/or reduce premature aging of the skin.
    Type: Application
    Filed: October 31, 2022
    Publication date: March 2, 2023
    Applicant: Plexus Worldwide, LLC
    Inventors: Tianan Jiang, Cynthia Latham, Stephen Roman, Randa Nabaty, Christin Powell
  • Publication number: 20220257692
    Abstract: Various embodiments provide a method of increasing immunity to a virus in a subject. The method can comprise: administering to the subject one or more effective doses of an immune-enhancing natural-based composition; thereby stimulating increased expression one or more of IFN-?, IL-1B, IL-6, IL-10, IL-12p40, IL-12p70, and TNF-?; inhibiting replication of the virus inside a cell of the subject, and preventing entry of virus into the cell. The method of increasing immunity can further comprise increasing immunity to an upper respiratory tract viral infection. The upper respiratory tract viral infection can be COVID-19. According to some aspects of the method of increasing immunity, the effective dose of the immune-enhancing natural-based composition comprises: 30-70 mgs of cyanidin-3-glucosides; 40-80 mgs of andrographolides; 75-125 mgs of ascorbic acid; 400-600 mgs of beta glucans; 300-500 mgs of polysaccharides; and 75-125 mgs of a blend of antioxidants.
    Type: Application
    Filed: February 17, 2022
    Publication date: August 18, 2022
    Applicant: Plexus Worldwide, LLC
    Inventors: Michael Hartman, Lauren Knutsen, Michael Rogowski
  • Publication number: 20210069088
    Abstract: Various embodiments provide topical compositions and methods for treating the skin to modulate the skin microbiome. The application of various embodiments of the topical composition may modulate the growth of various commensal bacterial in the skin microbiome when applied to the skin, which may improve the immune function of the skin and/or reduce premature aging of the skin.
    Type: Application
    Filed: March 8, 2019
    Publication date: March 11, 2021
    Applicant: Plexus Worldwide, LLC.
    Inventors: Tianan Jiang, Cynthia Latham, Stephen Roman, Randa Nabaty, Christin Powell